CPRX
Catalyst Pharmaceuticals Inc
NASDAQ: CPRX · HEALTHCARE · BIOTECHNOLOGY
$28.26
-4.01% today
Updated 2026-04-29
Market cap
$3.45B
P/E ratio
16.82
P/S ratio
5.86x
EPS (TTM)
$1.68
Dividend yield
—
52W range
$19 – $33
Volume
1.5M
Catalyst Pharmaceuticals Inc (CPRX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | $488958.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $500000.00 | $102.31M | $119.07M | $140.83M | $214.20M | $398.20M | $491.73M | $588.99M |
| Revenue growth (YoY) | — | — | — | — | — | -100.0% | — | — | — | — | — | — | — | +20361.3% | +16.4% | +18.3% | +52.1% | +85.9% | +23.5% | +19.8% |
| Cost of revenue | — | — | — | — | $4.49M | $6.04M | $0.00 | $0.00 | $0.00 | $34468.00 | $43406.00 | $45689.00 | $19.92M | $14.76M | $17.04M | $21.88M | $34.39M | $51.97M | $68.84M | $87.25M |
| Gross profit | — | — | — | — | $488958.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-34468.00 | $-43406.00 | $-45689.00 | $500000.00 | $87.55M | $102.03M | $118.95M | $179.81M | $346.24M | $422.89M | $501.74M |
| Gross margin | — | — | — | — | 100.0% | — | — | — | — | — | — | — | 100.0% | 85.6% | 85.7% | 84.5% | 83.9% | 86.9% | 86.0% | 85.2% |
| R&D | $989144.00 | $2.99M | $8.71M | $5.10M | $2.31M | $3.38M | $2.66M | $8.10M | $10.12M | $11.80M | $11.37M | $11.38M | $19.92M | $18.84M | $16.50M | $16.94M | $19.79M | $93.15M | $12.65M | $12.71M |
| SG&A | $1.91M | $2.04M | $2.18M | $2.18M | $2.21M | $2.70M | $2.56M | $2.21M | $4.47M | $8.60M | $7.91M | $7.30M | $15.88M | $36.88M | $20.67M | $23.48M | $28.71M | $47.02M | $167.74M | $193.75M |
| Operating income | $-2.90M | $-5.03M | $-10.89M | $-7.28M | $-4.02M | $-6.08M | $-5.22M | $-10.31M | $-14.59M | $-20.40M | $-19.28M | $-18.68M | $-35.30M | $31.82M | $41.30M | $52.38M | $101.84M | $86.81M | $195.12M | $257.78M |
| Operating margin | — | — | — | — | -823.0% | — | — | — | — | — | — | — | -7059.0% | 31.1% | 34.7% | 37.2% | 47.5% | 21.8% | 39.7% | 43.8% |
| EBITDA | $-2.72M | $-5.01M | $-10.53M | $-7.21M | $-4.00M | $-6.35M | $-6.35M | $-8.40M | $-13.57M | $-20.46M | $-18.03M | $-18.49M | $-35.26M | $32.12M | $42.19M | $52.58M | $103.08M | $119.69M | $232.90M | $321.01M |
| EBITDA margin | — | — | — | — | -817.7% | — | — | — | — | — | — | — | -7051.4% | 31.4% | 35.4% | 37.3% | 48.1% | 30.1% | 47.4% | 54.5% |
| EBIT | $-2.73M | $-5.03M | $-10.56M | $-7.24M | $-4.02M | $-6.39M | $-6.36M | $-8.42M | $-13.60M | $-20.50M | $-18.07M | $-18.54M | $-35.30M | $31.82M | $41.30M | $52.38M | $101.84M | $86.81M | $195.12M | $283.51M |
| Interest expense | $0.00 | $0.00 | $329348.00 | $33466.00 | $17858.00 | $10985.00 | $14976.00 | $47421.00 | $76233.00 | $100389.00 | $321612.00 | $454163.00 | $1.29M | $1.88M | $1.47M | $474000.00 | $4.12M | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-2.73M | $-4.14M | $-10.56M | $-7.24M | $-4.01M | $-6.39M | $-4.08M | $-12.15M | $-15.51M | $-20.23M | $-18.07M | $-18.41M | $-34.00M | $31.88M | $74.98M | $39.48M | $83.08M | $71.41M | $163.89M | $214.33M |
| Net income growth (YoY) | — | -51.7% | -155.2% | +31.5% | +44.7% | -59.5% | +36.2% | -198.2% | -27.6% | -30.5% | +10.7% | -1.9% | -84.7% | +193.7% | +135.2% | -47.3% | +110.4% | -14.0% | +129.5% | +30.8% |
| Profit margin | — | — | — | — | -819.4% | — | — | — | — | — | — | — | -6800.7% | 31.2% | 63.0% | 28.0% | 38.8% | 17.9% | 33.3% | 36.4% |